GARRETT L WALSH to Carcinoma, Ductal, Breast
This is a "connection" page, showing publications GARRETT L WALSH has written about Carcinoma, Ductal, Breast.
Connection Strength
0.094
-
A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer. Br J Cancer. 2009 Jan 27; 100(2):305-10.
Score: 0.052
-
Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma. Br J Cancer. 2006 Feb 13; 94(3):358-62.
Score: 0.042